Elizabeth J. Brooks

Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in <i>Mycobacterium tuberculosis</i> Infected C3HeB/FeJ Mice

Scott M. Irwin, Brendan Prideaux, Edward Lyon et al. · ACS Infectious Diseases · 2016 · 155 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

Limited Activity of Clofazimine as a Single Drug in a Mouse Model of Tuberculosis Exhibiting Caseous Necrotic Granulomas

Scott M. Irwin, Veronica Gruppo, Elizabeth J. Brooks et al. · Antimicrobial Agents and Chemotherapy · 2014 · 115 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +14

Comparative Studies Evaluating Mouse Models Used for Efficacy Testing of Experimental Drugs against <i>Mycobacterium tuberculosis</i>

Mary Ann De Groote, Janet C. Gilliland, Colby L. Wells et al. · Antimicrobial Agents and Chemotherapy · 2010 · 101 citations

Medicine, Infectious Diseases, Pharmacology +13

GM-CSF knockout mice for preclinical testing of agents with antimicrobial activity against Mycobacterium abscessus

Mary Ann De Groote, LaRue W. Johnson, Brendan K. Podell et al. · Journal of Antimicrobial Chemotherapy · 2013 · 67 citations · Full text

Medicine, Microbiology, Pharmacology +15

In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid

Laetitia Lucretia Ismarelda Josephine Booysen, Lonji Kalombo, Elizabeth J. Brooks et al. · International Journal of Pharmaceutics · 2013 · 64 citations

Pharmacy, Pharmaceutics, Pharmacology +16